Loading, please wait ...


News Analytics

1ef1cd0c 384c 4889 82c8 58bd42054fb8?size=1.
• Extension of collaboration between UTHealth and Immatics until end of 2024 providing Immatics exclusive access to state-of-the art cGMP manufacturing infrastructure at The Evelyn H. Griffin Stem Cell Therapeutics Research Laboratory • Collaboration ensures continued clinical batch supply for all of Immatics’ ongoing and next Adoptive Cell Therapy (ACT) clinical trials in US and Europe Houston, Texas, August 6, 2020 – Immatics N.V. (NASDAQ: ...
Google

Subject Matter

  • Science and technology 55.74%
  • Healthcare 44.26%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions